94
Participants
Start Date
March 8, 2018
Primary Completion Date
August 29, 2020
Study Completion Date
August 29, 2020
ONIVYDE
irinotecan liposome injection
5-fluorouracil
a nucleoside metabolic inhibitor
Leucovorin
an active metabolite of folic acid
National Cancer Center, Gyeonggi-do
Ajou University Hospital, Suwon
Konyang University Hospital, Daejeon
Severance Hospital, Yonsei University Health System - Gastroenterology, Seoul
Severance Hospital, Yonsei University Health System - Oncology, Seoul
ASAN Medical Center, Seoul
Gangnam Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center - Oncology, Seoul
The Catholic University of Korea Seoul St.Mary's Hospital, Seoul
Korea University Guro Hospital, Seoul
ADIR, a Servier Group company
INDUSTRY
Institut de Recherches Internationales Servier
OTHER